Ferra Joseph J Jr 4
4 · Elevation Oncology, Inc. · Filed Jun 18, 2024
Insider Transaction Report
Form 4
Ferra Joseph J Jr
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Tax Payment
Common Stock
2024-06-16$3.23/sh−4,628$14,948→ 93,614 total - Exercise/Conversion
Common Stock
2024-06-16+12,562→ 98,242 total - Exercise/Conversion
Restricted Stock Unit
2024-06-16−12,562→ 50,247 total→ Common Stock (12,562 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- [F2]25% of the RSUs vested on June 16, 2022, and the remainder will vest as to 1/16 of the total RSUs quarterly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
- [F3]The RSUs do not expire; they either vest or are canceled prior to the vesting date.